| Director, AI Customer Engagement, US Oncology | AstraZeneca | Gaithersburg, United States | 2026-06-25 |
| Academic Alliance Sr. Manager/Associate Director | AstraZeneca | Beijing, China | 2026-06-25 |
| Head of Central GA | AstraZeneca | Beijing, China | 2026-06-25 |
| Associate Director, Operations | AstraZeneca | Shanghai, China | 2026-06-25 |
| Director, AI Solution Consulting | AstraZeneca | United Kingdom | 2026-06-25 |
| Director, Immunology Scientific Innovation | AstraZeneca | Waltham, United States | 2026-06-25 |
| Principal/Associate Director, Project Management Lead (Cell Therapy) | AstraZeneca | United Kingdom | 2026-06-25 |
| Director, Oncology Bioanalytical Strategy Lead | AstraZeneca | Waltham, United States | 2026-06-25 |
| Director Site Management & Monitoring - Cell Therapy | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| Statistical Programming Director | AstraZeneca | Gaithersburg, United States | 2026-06-25 |
| Director, Theranostics and Radiation Science | AstraZeneca | Boston, United States | 2026-06-25 |
| Associate Director, Digital & Business Process Strategy | AstraZeneca | Rockville, United States | 2026-06-25 |
| Director, Integrated Bioanalysis Oncology Development | AstraZeneca | Cambridge, United States | 2026-06-25 |
| Associate Director, Safety Epidemiology โ Global Patient Safety | AstraZeneca | Luton, United Kingdom | 2026-06-25 |
| (Associate) Director, Pharmacometrics | AstraZeneca | Shanghai, China | 2026-06-25 |
| Head of Statistical Programming | AstraZeneca | Boston, United States | 2026-06-25 |
| Director, Site Management & Monitoring | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| Associate Director, Field Omnichannel Strategy | AstraZeneca | Wilmington, United States | 2026-06-25 |
| Senior Director/ Executive Director, Safety Sciences China | AstraZeneca | Shanghai, China | 2026-06-25 |
| Director, Project Toxicologist, Safety Sciences China | AstraZeneca | Shanghai, China | 2026-06-25 |
| (Associate) Director- Ecosystem Partnership, BD | AstraZeneca | Shanghai, China | 2026-06-25 |
| Public Policy Executive | AstraZeneca | Istanbul, Turkey | 2026-06-25 |
| Patient Access Executive - Singapore | AstraZeneca | Singapore, Singapore | 2026-06-25 |
| Principal/Associate Director, Project Management Lead (Oncology) | AstraZeneca | United Kingdom | 2026-06-25 |
| Director, Site Management & Monitoring (SMM BioPharmaceuticals) | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| Director, Bacterial Vaccine Discovery | AstraZeneca | Gaithersburg, United States | 2026-06-25 |
| Head of Data & AI Platforms, Beijing | AstraZeneca | Beijing, China | 2026-06-25 |
| Director, Agentic AI Platform, China | AstraZeneca | United Kingdom | 2026-06-25 |
| Associate Director (m/f/d), Computational Pathology Biomarker Lead (Oncology/BioPharma) | AstraZeneca | Azerbaijan | 2026-06-25 |
| Statistical Programming, Associate Director | AstraZeneca | Bengaluru, India | 2026-06-25 |
| (Asst.) Director, Biomolecular Technologies | Novo Nordisk | Beijing, China | 2026-06-25 |
| ้ซ็บง็ป็๏ผๅคงๅบ้ถๅฎ-ๅนฟๅท | Novo Nordisk | Guangzhou, China | 2026-06-25 |
| Associate Media Relations and Issues Management Director | Novo Nordisk | United States | 2026-06-25 |
| ไธๅกๆฏๆๅฏ็ป็-ๅนฟๅท-่ฐๅฒ็ด | Novo Nordisk | Guangzhou, China | 2026-06-25 |
| Associate e-Health Channel Director | Novo Nordisk | Singapore, Singapore | 2026-06-25 |
| National Pharmacy Strategy & Partnerships Manager | Novo Nordisk | Sydney, Australia | 2026-06-25 |
| Associate Media Relations and Issues Management Director | Novo Nordisk | United States | 2026-06-25 |
| Associate Human Resource Business Partner | Novo Nordisk | Clayton, United States | 2026-06-25 |
| Associate Director, Real World Evidence | Novo Nordisk | Ontario, United States | 2026-06-25 |